News
Kirkland & Ellis lawyers withdrew from representing Novartis AG in a lawsuit against Regeneron Inc. a week after the firm was ...
Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that its UG 100 ™ sequencing platform has been selected to support Regeneron Genetics ...
Cornerstone Wealth Group LLC doubled down on Regeneron Pharmaceuticals, increasing its holdings by 114% in Q1. The fund now ...
Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...
Several companies on the Wall Street have seen some Seeking Alpha analyst activity, including both upgrades and downgrades in ...
The Nasdaq 100 Index jumped to a record high this week, helped by the ongoing demand for artificial intelligence solutions ...
Patients with eosinophilic esophagitis in the US have high health care resource utilization costs, according to a retrospective national claims study.
ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced that it has received an extension of 180 calendar ...
The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results